Form 4: Oncology Institute Director Receives Stock Grant
Insider Transaction (Form 4)
Anne Mcgeorge, a Director of Oncology Institute, Inc., received 41,165 shares of common stock on July 27, 2026.
Summary
- Grant/award: acquired 41,165 Common Stock on July 27, 2026; holds 332,535 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Anne Mcgeorge — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Grant/award | Common Stock | 41,165 | — | — | 332,535 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Grant/award (41,165 shares) |
Keywords
insider transaction, Form 4, TOI, Oncology Institute, Inc., neutral, Anne Mcgeorge
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.